黏附包裝：市場佔有率分析、行業趨勢和成長預測（2025-2030 年）

Adherence Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

出版日期: 2025年03月18日 | 出版商:

Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

黏性包裝市場規模預計在 2025 年為 11.1 億美元，預計到 2030 年將達到 15.4 億美元，預測期內（2025-2030 年）的複合年成長率為 6.72%。

關鍵亮點

依從性包裝主要用於醫療保健領域，可以簡化藥物管理，取代傳統的錠劑筆記本。這種包裝適合患者的日常生活，使他們能夠按照醫療保健提供者的指示及時準確地服用處方箋。
對於慢性阻塞性肺病(COPD) 的患者來說，藥物治療和疾病管理依從性差是導致緊急住院的一個已知因素。因此，對黏性包裝的需求正在上升，預計在不久的將來會大幅成長。
此外，越來越注重減少藥物浪費正在加強依從性包裝領域。廢棄物不僅給醫療保健財務帶來壓力，也帶來環境風險。然而，該行業面臨挑戰，尤其是高昂的實施、安裝和維護成本，這可能會阻礙全球擴張。
包裝技術的最新進展整合了使用近距離場通訊(NFC) 和無線射頻識別 (RFID) 的數位擷取功能。這些創新旨在加強檢驗過程。單位劑量泡殼包裝具有被動、主動和互動元素，在應對鴉片類藥物危機和提高用藥安全性方面處於領先地位。被動元素包括圖形和基於文字的警告，而主動功能則利用電子設備進行及時提醒和警報。互動功能允許患者參與包裝並協助藥物追蹤和成癮管理。
許多公司正在積極推行新產品發布和策略夥伴關係等策略，以在不斷變化的環境中保持競爭力。尤其是技術主導的藥物依從性公司 Acute Technology 正在推廣其 Hydra Communications Gateway。該技術可讓智慧型手機使用者以電子方式監控他們的藥物攝取量，從而解決管理每週托盤上分發的藥物的擔憂。
吉利德、禮來等製藥巨頭正站在對抗新冠肺炎疫情的最前線。他們的股價飆升，反映出人們對創新的重新關注，特別是在感染疾病領域。由於迫切需要尋找 COVID-19 治療方法，這種活動的增加可能會對依從性包裝市場產生重大影響。總之，先進的包裝和主要製藥公司對 COVID-19 治療的投資增加預計將推動依從性包裝市場的顯著成長。

依從性包裝市場趨勢

多劑量包裝可望大幅成長

服藥依從性和同步用藥的好處日益重要，刺激了多劑量包裝解決方案的出現。多劑量泡殼卡具有多種優點，包括簡化給藥時間表以減少混亂、鼓勵自我治療和減少每月的藥房就診次數。大量研究表明，多劑量泡殼包裝可提高藥物依從性和健康結果，尤其是與藥物治療管理 (MTM) 結合時。
根據印度品牌資產基金會（IBEF）的報告，印度24會計年度（截至2024年2月）的醫藥出口額預計將達到250億美元，高於23會計年度的254億美元。在全球供應鏈中斷、停工和製造業放緩的背景下，這種韌性令人矚目。值得注意的是，美國、比利時、南非、英國和巴西已成為印度23會計年度的主要出口目的地。印度的表現對全球製藥業至關重要，並且表現出了堅定不移的可靠性，尤其是在經濟狀況不利的時候。
據 IBEF 稱，印度擁有在美國境外營運的符合 USFDA 要求的公司數量最多。值得注意的是，全球前20大學名藥公司中有8家是印度公司，其出口產品中有一半以上（55%）銷往受到嚴格監管的市場。作為主要的疫苗出口國，印度滿足了世界衛生組織 (WHO) 65-70% 的疫苗需求。
Omnicell 的研究結果強調了多重藥物包裝對病患依從性的影響。最初，這群患者的依從率為 80%，但到研究結束時，這一比例飆升至 90%。相較之下，僅依賴錠劑的患者的藥物依從性僅為 56%。 Omnicell 的解決方案 SureMed+ 是為期七天、四劑量、冷封、雙折卡，在 Omnicell 向 Holyoke Health Center 提供 Multi-Med 泡殼 Card 後，Holyoke Health Center 也採用了這種卡。
電子商務參與企業越來越注重便利性、合規性和增強老年人醫療保健包裝。亞馬遜去年收購 PillPack 證實了線上藥品配送的需求不斷成長，並表明人們對多藥包的興趣正在上升。隨著 COVID-19 的爆發，多劑量包裝至關重要，因為它旨在簡化處方箋處理、最大限度地減少「接觸點」並減少自我用藥錯誤。

北美佔據市場主導地位

北美地區經濟繁榮，人口老化，醫療體系先進。然而，各國的人口規模、衛生支出、國內生產總值（GDP）水準、醫療保險制度等存在很大差異。美國擁有先進的初級保健社區、廣泛的醫學和生命科學研究活動、較高的醫療保健支出強度以及龐大的製藥、醫療用品和醫療設備產業，是世界上最大的黏性包裝產品市場之一。
此外，美國懲教機構的服藥順從性正在提高。大多數懲教機構中的囚犯都依賴外部藥房處方箋。在某些情況下，藥劑師可能會在現場。然而，此類人員配備通常有限，他們依賴集中地點供應藥品，並依靠現場護理長或其他人來分發藥物。因此，越來越需要一種減輕員工負擔、管理良好的藥局管理系統，以確保患者遵守用藥規定。
據 Parata Systems 稱，服藥依從性差每年平均給美國造成 3,000 億美元的損失。袋裝包裝降低了醫療成本並改善了患者的治療效果。隨著條狀包裝在市場上變得越來越重要，患者意識的提高預計將給沒有適當包裝的藥局帶來壓力。該公司已針對藥局推出了 Parata PASSTM 36。 Parata Systems 是一家藥房自動化系統供應商，提供包括管瓶填充、依從性包裝、工作流程和患者體驗解決方案，該公司推出了一款名為 PASSTM 36 的袋裝包裝機。
該地區的公司致力於幫助人們堅持服藥並改善治療效果。為了實現這一目標，他們擴大與創新市場參與企業夥伴關係，特別是參與企業與藥局有密切聯繫的公司。透過這樣做，這些公司旨在擴大其服務對象的覆蓋範圍。透過利用其主要包裝專業知識和與藥房領導的關係，這些公司準備開發提高依從性的解決方案並擴大其影響力。
堅持用藥對於成功的治療結果至關重要，並且可以顯著減少昂貴的住院需求。在這種情況下，數位治療支持越來越受到關注。這種支援不僅限於傳統的穿戴式感測器和應用程式，還包括連接的主要包裝和輸送系統以及先進的藥物依從性監測。因此，合作夥伴關係和協作正在興起，為藥局提供雲端基礎的軟體和設備。這些工具使藥局能夠以最少的工作流程調整快速部署依從性解決方案，從而改善患者的健康狀況並開闢新的收益來源。

黏附包裝產業概況

黏性包裝市場呈現半靜態狀態，由少數重要參與企業組成。 Cardinal Health Inc.、WestRock Company、Omnicell Inc.、Parata Systems LLC 和 Keystone Folding Box Co. 等公司佔據了很大市場佔有率。市場也出現了多種產品發布和合作。

2024年4月，製藥、生物技術和化妝品行業的全球合作夥伴Gerresheimer最近與美國數位健康公司RxCap合作並收購了少數股權。透過此次合作，Gerresheimer 的子公司 Centor 將獲得 RxCap 在美國藥局的依從性解決方案的獨家經銷權。這些解決方案包括連接的管瓶封蓋和雲端基礎的軟體，並將增強 Centor 的現有產品。此舉凸顯了 Gerresheimer 致力於為客戶提供整合包裝和數位監控解決方案的承諾。

2024 年 4 月，加拿大醫療供應商 Healthmark Services Ltd.（RICHARDS Packaging Inc. 的一個部門）與 JFCRx 建立合作。此次合作使 Healthmark Services Ltd 成為 JFCRx 依從性袋包裝、測試和半自動管瓶填充藥局自動化設備的唯一供應商。 JFCRx 以其「分析主導的自動化」而聞名，它為藥局提供即時資料洞察，以提高業務效率和盈利。該公司的旗艦產品 TruPak 整合了先進的硬體和軟體，提供 RFID 智慧罐、可自訂的袋子尺寸和即時補貨等功能，以減少勞動力並提高安全性。

其他福利

Excel 格式的市場預測 (ME) 表
3個月的分析師支持

Key Highlights

Adherence packaging, predominantly utilized in healthcare, serves to streamline medication management, replacing traditional pill organizers. This packaging aligns with patients' daily routines, facilitating timely and accurate prescription intake as directed by healthcare providers.
Inadequate adherence to pharmacological therapy and illness management is a known factor leading to emergency hospitalizations among those with chronic obstructive pulmonary disease (COPD). Consequently, the demand for adherence packaging is on the rise, with projections indicating substantial growth in the near future.
Furthermore, a heightened focus on minimizing drug waste is bolstering the adherence packaging sector. Waste not only strains healthcare finances but also poses environmental risks. Yet, the industry faces challenges, notably in the form of high implementation, installation, and maintenance costs, which could potentially impede its global expansion.
Recent advancements in packaging technology are integrating digital capture features utilizing near-field communication (NFC) or radio frequency identification (RFID). These innovations aim to enhance verification processes. Unit-dose blisters, equipped with passive, active, and interactive elements, are at the forefront of combating the opioid crisis and bolstering pharmaceutical safety. Passive components include graphic or text-based alerts, while active features leverage electronics for timely reminders or alarms. Interactive functionalities empower patients to engage with the packaging, aiding in dose recording and addiction management.
Several companies are actively pursuing strategies, like new product launches and strategic partnerships, to stay competitive in this evolving landscape. Notably, Acute Technology, a company in tech-driven medication adherence, is championing the Hydra Communications Gateway. This technology could potentially allow smartphone users to monitor their dosages electronically, addressing concerns around the control of medications dispensed via weekly trays.
Pharmaceutical giants like Gilead and Eli Lilly are at the forefront of the battle against COVID-19. Their stocks are surging, reflecting a renewed focus on innovation, especially in infectious diseases. This heightened activity, driven by the urgent quest for COVID-19 treatments, is poised to have a substantial impact on the adherence packaging market. In conclusion, the advancements and increased investments in COVID-19 therapies by leading pharmaceutical companies are expected to drive significant growth in the adherence packaging market.

Adherence Packaging Market Trends

Multi-dose Packaging is Expected to Witness Significant Growth

The rising significance of medication adherence and the advantages of synchronizing medications have spurred the emergence of multi-dose packaging solutions. Multi-dose blister cards offer several benefits, such as streamlining dosage schedules to reduce confusion, facilitating self-medication, and reducing monthly pharmacy visits. Numerous studies underscore the enhanced adherence and health outcomes associated with multi-med blister packs, especially when coupled with medication therapy management (MTM).
As reported by the India Brand Equity Foundation (IBEF), India's drug and pharmaceutical exports in FY 2024 (until February 2024) reached USD 25.0 billion, from USD 25.4 billion recorded in FY 2023. This resilience is notable, given the backdrop of global supply chain disruptions, lockdowns, and subdued manufacturing. Notably, the United States, Belgium, South Africa, the United Kingdom, and Brazil emerged as India's primary export destinations in FY 2023. India's performance underscored its pivotal role in the global pharma landscape, showcasing unwavering reliability even in the face of crises, notably exemplified during the COVID-19 pandemic.
According to IBEF, India boasts the highest number of USFDA-compliant companies operating outside the United States. Notably, 8 out of the top 20 global generic companies hail from India, and more than half (55%) of the country's exports target highly regulated markets. Given its status as a major vaccine exporter, India fulfills a substantial 65-70% of the World Health Organization's (WHO) vaccine demand.
Findings from an Omnicell survey underscore the impact of multimed packaging on patient adherence. Initially, patients in this group achieved an 80% adherence rate, which surged to an impressive 90% by the trial's end. In contrast, patients relying solely on pill bottles managed a modest 56% adherence rate. Omnicell's solution, the SureMed+, a seven-day, four-time pass, cold-seal, bi-fold card, was adopted by Holyoke Health Center following Omnicell's provision of multimed blister cards.
E-commerce players are increasingly focusing on enhancing convenience, compliance, and tailored healthcare packaging for the elderly. Amazon's acquisition of PillPack last year underscores the rising demand for online medication delivery, hinting at a growing interest in multi-med packs. With the onset of COVID-19, multi-dose packaging is crucial, aiming to streamline prescription processing, minimize 'touchpoints,' and mitigate self-medication errors.

North America Dominates the Market

The North American region is developed with prosperous economies, aging population segments, and advanced medical delivery systems. Still, the countries vary measurably in population size, healthcare spending intensities, aggregate gross domestic product (GDP) levels, and the structure of health insurance plans. With an advanced primary medical community, extensive medical and life science research activities, high healthcare spending intensity, and large pharmaceutical and medical supply and device industries, the United States accounts for one of the world's largest geographical markets for adherence packaging products.
Furthermore, the United States is witnessing improved medication adherence in the correctional setting. The incarcerated population in most correctional facilities relies on an outside pharmacy to fill their prescriptions. An onsite pharmacist may be provided in some situations. However, such staff is often restricted, relying on a centralized location to supply drugs and an onsite nurse manager or similar to dispense. This strengthens the case for dispensing administration systems that are low-effort for personnel while yet being well-managed to ensure patient adherence.
As per Parata Systems, non-adherence to medication, on average, costs USD 300 billion/year in the United States. Pouch packaging has reduced the cost of care and improved patient outcomes. With the growing presence of strip packaging in the market, patient awareness is expected to pressure pharmacies without proper packaging to be left behind. The company launched Parata PASSTM 36, targeting pharmacies. Parata Systems, being a provider of pharmacy automation systems, including vial-filling, adherence packaging, and workflow and patient experience solutions, launched a pouch packager named PASSTM 36.
Businesses in the region are focused on a mission: helping people stay adherent to their medications and improving their care outcomes. To achieve this, they are increasingly forging partnerships with innovative market players, particularly those with strong ties to pharmacies. By doing so, these businesses aim to expand the reach of the patients they serve. Leveraging their expertise in primary packaging and their relationships with pharmacy leaders, these companies are poised to develop enhanced adherence solutions, thereby magnifying their impact.
Adherence to medication is pivotal to successful therapy outcomes and can significantly reduce the need for costly hospitalizations. In this landscape, digital therapy support is gaining prominence. This support extends beyond traditional body-worn sensors and apps, encompassing connected primary packaging, delivery systems, and advanced medication adherence monitoring. Consequently, collaborations and alliances are emerging, offering cloud-based software and devices to pharmacies. These tools empower pharmacies to swiftly introduce adherence solutions, bolstering patients' health journeys with minimal workflow adjustments and paving the way for new revenue streams.

Adherence Packaging Industry Overview

The adherence packaging market is semi-consolidated and consists of a few significant players. Companies like Cardinal Health Inc., WestRock Company, Omnicell Inc., Parata Systems LLC, and Keystone Folding Box Co. hold substantial market shares. The market is also witnessing multiple product launches and partnerships.

In April 2024, Gerresheimer, a global partner for the pharma, biotech, and cosmetics industries, recently partnered with US digital health company RxCap, acquiring a minority stake. In this collaboration, Gerresheimer's subsidiary, Centor, gains exclusive US pharmacy distribution rights for RxCap's adherence solutions. These solutions include connected prescription vial closures and cloud-based software, enhancing Centor's existing offerings. This move underscores Gerresheimer's commitment to providing customers with integrated packaging and digital monitoring solutions.

In April 2024, Canadian medical supplier Healthmark Services Ltd, a division of RICHARDS Packaging Inc., teamed up with JFCRx. This partnership designates Healthmark Services Ltd as the sole provider of JFCRx's adherence pouch packaging, inspection, and semi-automated vial filling pharmacy automation equipment. JFCRx, known for its "analytics-driven automation," empowers pharmacies with real-time data insights, enhancing operational efficiency and profitability. Their flagship product, TruPak, integrates advanced hardware and software, offering features like RFID smart canisters, customizable pouch sizes, and on-the-fly replenishment, ensuring both labor savings and enhanced safety.

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support

1 INTRODUCTION

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

4.1 Market Overview
4.2 Industry Supply Chain Analysis
4.3 Industry Attractiveness - Porter's Five Forces Analysis
- 4.3.1 Bargaining Power of Suppliers
- 4.3.2 Bargaining Power of Consumers
- 4.3.3 Threat of New Entrants
- 4.3.4 Threat of Substitute Products
- 4.3.5 Intensity of Competitive Rivalry
4.4 Assessment of the Impact of COVID-19 on the Industry

5 MARKET DYNAMICS

5.1 Market Drivers
- 5.1.1 Rise in Need to Minimize Medication Wastage
- 5.1.2 High Rate of Medication Non-adherence
5.2 Market Challenges
- 5.2.1 High Installation and Maintenance Costs of Automated Systems
- 5.2.2 Lack of Awareness Regarding Medication Adherence Packaging

6 GOVERNMENT REGULATIONS

7 MARKET SEGMENTATION

7.1 Material
- 7.1.1 Plastic (PE, PET, PVC, and PP)
- 7.1.2 Paper and Paperboard
- 7.1.3 Aluminum
7.2 Type
- 7.2.1 Unit-dose Packaging
- 7.2.2 Multi-dose Packaging
7.3 Packaging Type
- 7.3.1 Blisters
- 7.3.2 Pouches
- 7.3.3 Other Packaging Types
7.4 End-user Industry
- 7.4.1 Pharmacies
- 7.4.2 Hospitals
- 7.4.3 Other End-user Industries
7.5 Geography
- 7.5.1 North America
- 7.5.2 Europe
- 7.5.3 Asia-Pacific
- 7.5.4 Latin America
- 7.5.5 Middle East and Africa

8 COMPETITIVE LANDSCAPE

8.1 Company Profiles
- 8.1.1 Westrock Company
- 8.1.2 Keystone Folding Box Co.
- 8.1.3 Cardinal Health Inc.
- 8.1.4 Omnicell Inc.
- 8.1.5 Jones Healthcare Group
- 8.1.6 Drug Package LLC
- 8.1.7 Parata Systems LLC
- 8.1.8 Manrex Limited
- 8.1.9 Medicine-On-Time LLC
- 8.1.10 Rx Systems Inc.